ReShape Lifesciences Inc.
General ticker "RSLS" information:
- Sector: Health Care
- Industry: Health Care Equipment & Supplies
- Capitalization: $3.1M (TTM average)
ReShape Lifesciences Inc. does not follow the US Stock Market performance with the rate: -15.8%.
Estimated limits based on current volatility of 1.9%: low 2.47$, high 2.63$
Factors to consider:
- US accounted for 82.2% of revenue in the fiscal year ended 2023-12-31
Short-term RSLS quotes
Long-term RSLS plot
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $10.71MM | $8.71MM | $8.01MM |
| Operating Expenses | $57.06MM | $24.09MM | $14.67MM |
| Operating Income | $-46.35MM | $-15.38MM | $-6.67MM |
| Non-Operating Income | $-0.24MM | $4.05MM | $-0.42MM |
| R&D Expense | $2.54MM | $2.31MM | $1.80MM |
| Income(Loss) | $-46.59MM | $-11.34MM | $-7.09MM |
| Taxes | $-0.38MM | $0.05MM | $0.04MM |
| Profit(Loss)* | $-46.21MM | $-11.39MM | $-7.13MM |
| Stockholders Equity | $3.66MM | $6.66MM | $-0.25MM |
| Inventory | $3.61MM | $3.74MM | $2.46MM |
| Assets | $11.14MM | $10.66MM | $4.79MM |
| Operating Cash Flow | $-21.90MM | $-16.96MM | $-4.43MM |
| Capital expenditure | $0.13MM | $0.04MM | $0.00MM |
| Investing Cash Flow | $-0.09MM | $-0.01MM | $0.00MM |
| Financing Cash Flow | $3.13MM | $17.57MM | $0.68MM |
| Earnings Per Share** | $-6,315.92 | $-110.88 | $-13.83 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.